1. Benefits and limits of anticholinergic use in schizophrenia: Focusing on its effect on cognitive function. Issue 1 (19th September 2013) Authors: Ogino, Shin; Miyamoto, Seiya; Miyake, Nobumi; Yamaguchi, Noboru Journal: Psychiatry and clinical neurosciences Issue: Volume 68:Issue 1(2014) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long‐term efficacy and safety of blonanserin in patients with first‐episode schizophrenia: A 1‐year open‐label trial. Issue 12 (7th July 2014) Authors: Ninomiya, Yuriko; Miyamoto, Seiya; Tenjin, Tomomi; Ogino, Shin; Miyake, Nobumi; Kaneda, Yasuhiro; Sumiyoshi, Tomiki; Yamaguchi, Noboru Journal: Psychiatry and clinical neurosciences Issue: Volume 68:Issue 12(2014) Page Start: 841 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Retraction: 'Effect of blonanserin on cognitive function in antipsychotic‐naïve first‐episode schizophrenia'. (1st June 2017) Authors: Tenjin, Tomomi; Miyamoto, Seiya; Miyake, Nobumi; Ogino, Shin; Kitajima, Rei; Ojima, Kazuaki; Arai, Jun; Teramoto, Haruki; Tsukahara, Sachiko; Ito, Yukie; Tadokoro, Masanori; Anai, Kiriko; Funamoto, Yasuyuki; Kaneda, Yasuhiro; Sumiyoshi, Tomiki; Yamaguchi, Noboru Journal: Human psychopharmacology Issue: Volume 32:Number 3(2017:Apr.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗